MedPath

A randomised clinical trial comparing hydrocolloid, phenytoin and simple dressing in the treatment of pressure ulcer

Not Applicable
Completed
Conditions
Pressure ulcer
Skin and Connective Tissue Diseases
Decubitus ulcer
Registration Number
ISRCTN33429693
Lead Sponsor
Janbazan Medical and Engineering Research Centre (JMERC)
Brief Summary

2004 results in http://www.ncbi.nlm.nih.gov/pubmed/15601464

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Male
Target Recruitment
83
Inclusion Criteria

Current information as of 19/08/09:
1. Paraplegia caused by spinal cord injury
2. Pressure ulcer stage I and II according to Shea classification or National Pressure Ulcer Advisory Panel
3. Patient's informed consent
4. Smoothness of ulcer area to establish whether adhesive could be used at the site

Initial information at time of registration:
83 spinal cord victims of IRAN-IRAQ with pressure ulcer

Exclusion Criteria

Added 19/08/09:
1. Addiction
2. Heavy smoking (more than 20 cigarettes a day or more than 10 packs per year
3. Concomitant chronic disease (e.g. diabetes mellitus or frank vascular disease such as Buerger's disease)

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<br> 1. Ulcer healing<br> 1.1 Complete ulcer healing, defined as:<br> 1.1.1. For stage I ulcer, intact epidermis, no red area<br> 1.1.2. For stage II ulcers, intact dermis and epidermis, no abrasion or ulceration.<br> 1.2. Partial healing, defined as any decrease in ulcer size compared to the baseline ulcer tracing, excluding complete healing<br> 1.3. Without improvement, defined as no change in ulcer size compared to the baseline ulcer tracing<br> 1.4. Worsening, defined as any increase in ulcer size compared to the baseline ulcer tracing.<br> 2. Response rate<br>
Secondary Outcome Measures
NameTimeMethod
ot provided at time of registration
© Copyright 2025. All Rights Reserved by MedPath